Please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor.

Research Centre

This page tells you at a glance what is happening in the market.

Chart Snapshot

FTSE 100 | 7368.17 | +39.25
FTSE 250 | 20220.77 | +73.61
Dow Jones I.A. | 24462.94 | -201.95
Xetra DAX | 12540.50 | -26.92
CAC 40 | 5412.83 | +21.19


Name Value Today Change %
FTSE 100 7368 0.54
FTSE 250 20221 0.37
FTSE 350 4112 0.51
FTSE Small Cap 5820 0.20
FTSE All-Share 4062 0.49
FTSE Fledgling 10757 0.01
FTSE techMARK Focus 4533 -0.06
FTSE AIM All-Share 1034 0.13
FTSE AIM 50 5907 -0.38
FTSE AIM 100 5347 -0.04
CAC 40 5413 0.39
Xetra DAX 12540 -0.21
AEX Index 550 -0.17
BEL 20 3921 0.24
Dow Jones I.A. 24463 -0.82
Nasdaq 100 6668 -1.58


Monitor your chosen stocks with a watchlist.

Top Movers

Name Price %
Ultra Electronics Holdings 1,405.00p +6.20
Capita 159.80p +5.72
On The Beach Group 610.00p +4.27
Intu Properties 202.30p +4.09
CRH 2,525.00p +4.08
Hammerson 540.00p +3.97
Name Price %
Shire Plc 3,821.50p -3.86
Bakkavor Group 182.00p -3.19
Greene King 562.60p -3.13
Melrose Industries 229.20p -2.96
Countryside Properties 360.40p -2.86
Reckitt Benckiser Group 5,625.00p -2.78


Takeda bumps up proposed offer for Shire

(WebFG News) - Shire received an improved takeover offer from Takeda Pharmaceutical on Friday, a day after turning down a £46.50 bid made up of shares and cash.

Burberry appoints former Belstaff boss as chief commercial officer

(WebFG News) - Burberry has appointed industry veteran Gavin Haig - the former chief executive of fashion heritage brand Belstaff - to the newly-created role of chief commercial officer, with effect from next Monday.

Hikma launches generic injectable version of Zinecard

(WebFG News) - Hikma Pharmaceuticals has launched a generic injectable product to counter a shortage in the US market for products to counter heart problems associated with commonly prescribed chemotherapy drug.

Countryside Properties falls as Oaktree Capital sells entire stake

(WebFG News) - Countryside Properties was in the red on Friday after OCM Luxembourg Coppice Topco - an entity owner by asset manager Oaktree Capital - sold its entire 8% stake in the housebuilder and urban regeneration company.

Fidessa agrees terms of £1.5bn Ion Investment bid; Temenos out in the cold

(WebFG News) - Financial technology group Fidessa agreed the terms of a £1.5bn offer from Dublin-based Ion Investment Group on Friday, just hours before the deadline to make a formal bid.

Sealand Capital disposes of SecureCom at considerable loss

(WebFG News) - Tech investment and acquisition firm Sealand Capital Galaxy has entered into a non-binding memorandum of understanding to dispose of its main business, SecureCom Media, to Creative Alpha for a nominal fee of £10,000.

Drax begins £50m share buyback programme

(WebFG News) - Drax Group announced on Friday that it is commencing a £50m share buy-back programme, in a bid to reduce its share capital.

Ryan Mangold steps down in Taylor Wimpey management shuffle

(WebFG News) - Taylor Wimpey announced on Friday that Ryan Mangold would be leaving his role as group finance director after almost eight years in that position, in a move that surprised analysts in the City.